The cutaneous manifestations of human parvovirus B19 infection

Human Pathology

Volumn 31, Issue 4, 2000, Pages 488-497

  Magro, Cynthia M ^a,b,c,d   Dawood, Magdy R ^a,b,c,d   Crowson, A Neil ^a,b,c,d,e  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Cadham Provincial Laboratories   (United States)

^c Central Medical Laboratories   (United States)

^d Regional Medical Laboratory   (United States)

^e ST JOHN MEDICAL CENTER   (United States)

Author keywords

Connective tissue disease; Dermatopathology; Parvovirus B19

Indexed keywords

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADULT; ARTICLE; DELAYED HYPERSENSITIVITY; DERMATOMYOSITIS; ERYTHEMA; ERYTHEMA INFECTIOSUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; LEUKOCYTOCLASTIC VASCULITIS; LUPUS ERYTHEMATOSUS; MALE; PARVOVIRUS; PETECHIA; SKIN BIOPSY; SKIN MANIFESTATION;

EID: 0034019597     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hp.2000.6714     Document Type: Article

References (44)

1. Bialecki C. Feder H.M. Jr Grant-Kels J.M. The six classic childhood exanthems: A review and update J Am Acad Dermatol 21 1989 891 903
2. Lewkonia R.M. Horne D. Dawood M.R. Juvenile dermatomyositis in a child infected with human parvovirus B19 Clin Infect Dis 21 1995 430 432
3. Nigro G. Piazze J. Taliani G. Postpartum lupus erythematosus associated with parvovirus B19 infection J Rheumatol 24 1997 968 970
4. Wright D.K. Manos M.M. Sample preparation from paraffinembedded tissues in PCR protocols: A guide to methods and applications Innis M.A. Gelfand D.H. Sninsky J.J. 1990 Academic Press San Diego, CA 153 158
5. Fridell E. Bekassy A.N. Larsson B. Polymerase chain reaction with double primer pairs detection of human parvovirus B19 induced aplastic crises in family outbreaks Scand J Infect Dis 24 1992 275 282
6. Dawood M.R. Allan R. Fowke K. Development of oligonucleotide primers of human immunodeficiency virus type 1 (HIV 1) and their use for amplification of HIV -1 provirus by usingpolymerise chain reaction J Clin Microbiol 30 1992 2279 2283
7. Mackie R. Young H. Association of Clinical Pathologists Broadsheet 110 1984 British Medical Association London, United Kingdom
8. Harrist T.J. Mihm M.C. Jr Cutaneous immunopathology: The diagnostic use of direct and indirect immunofluorescence techniques in diagnostic dermatopathology Hum Pathol 10 1979 625 653
9. Magro C.M. Crowson A.N. Harrist T.J. The use of antibody to C5b-9 in the subclassification of lupus erythematosus Br J Dermatol 134 1996 855 862
10. Magro C.M. Crowson A.N. The immunofluorescence findings in cutaneous lesions of dermatomyositis: A comparative study versus lupus erythematosus J Cutan Pathol 24 1997 543 552
11. Brown K.E. Young N.S. Parvovirus B19 in human disease Annu Rev Med 48 1997 59 67
12. Cohen B.J. Buckley M.M. The prevalence of antibody to human parvovirus B19 in England and Wales J Med Microbiol 25 1988 151 153
13. Aractingi S. Bakhos D. Flageul B. Immunohistochemical and virological study of skin in the papular-purpuric gloves and socks syndrome Br J Dermatol 135 1996 599 602
14. Grilli R. Izquierdo M.J. Farina M.C. Papular-purpuric “gloves and socks” syndrome: Polymerase chain reaction demonstration of parvovirus B19 DNA in cutaneous lesions and sera J Am Acad Dermatol 41 1999 793 796
15. Naides S.J. Piette W. Veach L.A. Human parvovirus B19 induced vesiculopustular skin eruption Am J Med 64 1988 968 972
16. Evans L.M. Grossman M.E. Gregory N. Koplik spots and a prupuric eruption associated with parvovirus B19 infection J Am Acid Dermatol 27 1992 466 467
17. Carrascosa J.M. Just M. Ribera M. Papular acrodermatitis of childhood related to poxvirus and parvovirus B19 infection Cutis 61 1998 265 267
18. Finkel T.H. Torok T.J. Ferguson P.J. Chronic parvovirus B19 infection and systemic necrotising vasculitis: Opportunistic infection or aetiological agent? Lancet 343 1994 1255 1258
19. Nikkari S. Mertsola J. Korvenranta H. Wegener's granulomatosis and parvovirus B19 infection Arthritis Rheum 37 1994 1707 1708
20. Staud R. Corman L.C. Association of parvovirus B19 infection with giant cell arteritis Clin Infect Dis 22 1996 1123
21. Wagner A.D. Goronzy J.J. Matteson E.L. Systemic monocyte and T-cell activation in a patient with human parvovirus B19 infection Mayo Clin Proc 70 1995 261 265
22. Magro C.M. Crowson A.N. A distinctive cutaneous reaction pattern indicative of infection by reactive arthropathy-associated microbial pathogens: The superandgen idreaction J Cutan Pathol 25 1998 538 544
23. Loong C.L. Coyle P.V. Anderson M.J. Human serum parvovirus associated vasculitis Postgrad Med J 62 1986 493 494
24. Ferguson P.J. Saulsbury F.T. Dowell S.F. Prevalence of human parvovirus B19 infection in children with Henoch-Schonlein purpura Arthritis Rheum 39 1996 880 881
25. Fukushige J. Takahashi N. Ueda K. Kawasaki disease and human parvovirus B19 antibody: Role of immunoglobulin therapy Acta Paediatr Jpn 37 1995 758 760
26. Schwarz T.F. Wiersbitzky S. Pambor M. Case report: Detection of parvovirus B19 in a skin biopsy of a patient with erythema infectiosum J Med Virol 43 1994 171 174
27. Pilavdzic D. Lines L.D. Petric M. Immunoelectron microscopic identification of human parvovirus B19 Ultrastruct Pathol 18 1994 417 422
28. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 1997 1725
29. Roblot P. Roblot F. Ramassamy A. Lupus syndrome after parvovirus B19 infection Rev Rhum Engl Ed 64 1997 849 851
30. Loizou S. Cazabon J.K. Walport M.J. Similarities of specificity and cofactor dependence in serum anti-phospholipid antibodies from patients with human parvovirus B19 infection andfrom those with systemic lupus erythematosus Arthritis Rheum 40 1997 103 108
31. Caramaschi P. Zeminian S. Carletto A. Parvovirus B19 infection and rheumatic diseases Rev Rheum Engl Ed 63 1996 846 853
32. Fawaz-Estrup F. Human parvovirus infection: Rheumatic manifestations, angioedema, C1 esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus J Rheumatol 23 1996 1180 1185
33. Nesher G. Osborn T.G. Moore T.L. Parvovirus infection mimicking systemic lupus erythematosus Semin Arthritis Rheum 24 1995 297 303
34. Vigeant P. Menard H. Boire G. Chronic modulation of the autoimmune response following parvovirus B19 infection J Rheumatol 21 1994 1165 1167
35. Glickstein S.L. Lupus-like presentation of human parvovirus B19 infection J Rheumatol 20 1993 1253
36. Cope A.P. Jones A. Brozovic M. Possible induction of systemic lupus erythematosus by human parvovirus Ann Rheum Dis 51 1992 803 804
37. Kalish R.A. Knopf A.N. Gary G.W. Lupus-like presentation of human parvovirus B19 infection J Rheumatol 19 1992 169 171
38. Koch W.C. Massey G. Russell C.E. Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients J Pediatr 116 1990 355 359
39. Takahashi Y. Murai C. Shibata S. Human parvovirus B19 as a causative agent for rheumatoid arthritis Proc Natl Acad Sci USA 95 1998 8227 8232
40. Crowson A.N. Magro C.M. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis Hum Pathol 27 1996 15 19
41. Lunardi C. Tiso M. Borgato L. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties Eur J Immunol 28 1998 936 948
42. Dwyer J.M. Erlendsson K. Intraventricular gamma-globulin for the management of enterovirus encephalitis Pediatr Infect Dis J 7 1988 S30 S33
43. Biron C.A. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections Semin Immunol 10 1998 383 390
44. Kerr J.R. Coyle P.V. DeLeys R.J. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection J Med Virol 48 1996 68 75